GLSHQ (Gelesis Holdings) Total Liabilities: $114.50 Mil (As of Jun. 2023)


What is Gelesis Holdings Total Liabilities?

Gelesis Holdings GLSHQ -99.00% Total Liabilities is $114.50 Mil as of Jun. 2023.

Gelesis Holdings's Total Liabilities for the quarter that ended in Jun. 2023 was $114.50 Mil.

Gelesis Holdings's quarterly Total Liabilities declined from Dec. 2022 ($115.79 Mil) to Mar. 2023 ($112.57 Mil) but then increased from Mar. 2023 ($112.57 Mil) to Jun. 2023 ($114.50 Mil).

Gelesis Holdings's annual Total Liabilities increased from . 20 ($0.00 Mil) to Dec. 2021 ($464.28 Mil) but then declined from Dec. 2021 ($464.28 Mil) to Dec. 2022 ($115.79 Mil).

Gelesis Holdings Total Liabilities Historical Data

* Premium members only.

The historical data trend for Gelesis Holdings's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gelesis Holdings Total Liabilities Chart

Gelesis Holdings Annual Data
Trend Dec21 Dec22
Total Liabilities
464.28 115.79

Gelesis Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only 122.78 123.64 115.79 112.57 114.50

Gelesis Holdings Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Gelesis Holdings's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=50.683+(26.309+1.237
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+37.337+0+0.224)
=115.79

Total Liabilities=Total Assets (A: Dec. 2022 )-Total Equity (A: Dec. 2022 )
=103.324--12.466
=115.79

Gelesis Holdings's Total Liabilities for the quarter that ended in Jun. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=50.241+(27.963+2.7755575615629E-15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+36.16+0+0.224)
=114.50

Total Liabilities=Total Assets (Q: Jun. 2023 )-Total Equity (Q: Jun. 2023 )
=95.875--18.625
=114.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $114.50 Mil mean?
Gelesis Holdings (GLSHQ) has a Total Liabilities of $114.50 Mil as of Jun. 2023. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Gelesis Holdings and its competitors.
Is Gelesis Holdings' Total Liabilities too high?
Gelesis Holdings' current Total Liabilities is $114.50 Mil.
How does Gelesis Holdings' Total Liabilities compare to RBSH and PPCB?
Gelesis Holdings' Total Liabilities of $114.50 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Gelesis Holdings and its competitors. Gelesis Holdings's current Total Liabilities is $114.50 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gelesis Holdings stock overvalued right now?
Gelesis Holdings (GLSHQ) has a current Total Liabilities of $114.50 Mil. The current Total Liabilities is $114.50 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Gelesis Holdings (GLSHQ), the current Total Liabilities is $114.50 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gelesis Holdings Business Description

Address 501 Boylston Street, Suite 6102, Boston, MA, USA, 02116
Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation.